Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Eli Lilly and Company
Age
20–65
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Participants are either Caucasian or first generation Japanese.
Participants' body mass index (BMI) is between 18.0 and 35.0 kilogram per meter square (kg/ m\^2).
You may not be if
Participants are heavy caffeine drinkers defined by regular intake of more than 5 cups of coffee (or equivalent in xanthine containing beverages) per day, and/or are unable or unwilling to abide by caffeine restrictions as specified in the protocol.
Participants are smoking within the previous 6 months.
Participants have received treatment with biologic agents (such as monoclonal antibodies) within 3 months or 5 half-lives (whichever is longer) prior to dosing or have received a vaccination within 1 month.
Participants have known allergies to LY2951742, related compounds or any components of the formulation, or history of significant atopy.
Participants are allergies to either humanized monoclonal antibodies, diphenhydramine, epinephrine, or methylprednisolone.
